Learn how long-acting injectable PrEP can transform HIV responses in South Africa while bridging treatment access gaps.
Long-acting Injectable PrEP: Transforming HIV Strategies
Original Article by Rowan Govender | Daily Maverick | 27 November 2025
Learn how long-acting injectable PrEP can transform HIV responses in South Africa while bridging treatment access gaps.
More Posts
Compounded semaglutide appeal dismissed
A court has upheld restrictions on compounded semaglutide at iDexis while regulatory investigations continue.
Read more...
WHO’s Africa Chief Urges Action, Not Talk, on Primary Healthcare
WHO Africa director Mohamed Janabi urged governments to finance primary healthcare and pursue health sovereignty.
Read more...
Unpaid specialist training strains SA doctors
Unpaid specialist training is growing in South Africa as scarce funded posts leave doctors working without salaries.
Read more...